Randomized controlled trials in evidence-based mental health care: Getting the right answer to the right question

Schizophrenia Bulletin

Volumn 29, Issue 1, 2003, Pages 115-123

  Essock, Susan M ^a,b   Drake, Robert E ^c   Frank, Richard G ^d   McGuire, Thomas G ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b New York Veterans Affairs Harbor Healthcare System   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Evidence based practice; Methodology; Randomized trial

Indexed keywords

CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; ECONOMIC ASPECT; EVIDENCE BASED MEDICINE; HUMAN; METHODOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TIME; TREATMENT PLANNING; VALIDATION PROCESS;

EID: 0037810937     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a006981     Document Type: Review

References (43)

1. Aguilera, R.; Anderson, A.; Gabrie, E.; Merlo, M.; Paredes, T.; and Pastrana, R. A clinical impact evaluation of integrated and disease specific substance abuse program models in Honduras. International Journal of Psychosocial Rehabilitation, 3:97-167, 2002.
2. Barrowclough, C.; Haddock, G.; Tarrier, N.; Lewis, S.; Moring, J.; O'Brien, R.; Schofield, N.; and McGovern, J. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with co-occurring schizophrenia and substance use disorder. American Journal of Psychiatry, 158:1706-1733, 2001.
3. Becker, D.R.; Drake, R.E.; Farabaugh, A.; and Bond, G.R. Job preferences among people with severe psychiatric disorders in supported employment programs. Psychiatric Services, 47:1223-1226, 1996.
4. Bond, G.R. Principles of the individual placement and support model: Empirical support. Psychiatric Rehabilitation Journal, 22:11-23, 1998.
5. Brunette, M.F.; Drake, R.E.; Woods, M.; and Hartnett, T. A comparison of long-term and short-term residential treatment programs for dual diagnosis patients. Psychiatric Services, 52:526-528, 2001.
6. Carey, K.B., and Carey, M.P. Enhancing the treatment attendance of mentally ill chemical abusers. Journal of Behavior Therapy and Experimental Psychiatry, 21:205-209, 1990a.
7. Carey, M.P., and Carey, K.B. Training mentally ill chemical abusers in social problem solving. Behavior Therapy, 21:511-519, 1990b.
8. Carmichael, D.; Tackett-Gibson, M.; and Dell, O. Texas Dual Diagnosis Project Evaluation Report 1997-1998. College Station, TX: Texas A&M University, Public Policy Research Institute, 1998.
9. Chiles, J.A.; Davidson, P.; and McBride, D. Effects of clozapine on use of seclusion and restraint at a state hospital. Hospital and Community Psychiatry, 45:269-271, 1994.
10. Creed, F.; Black, D.; Anthony, P.; Osborn, M.; Thomas, P.; and Tomenson, B. Randomized controlled trial of day patient versus inpatient psychiatric treatment. British Medical Journal, 300:1033-1037, 1990.
11. Cruz, M., and Pincus, H.A. Research on the influence that communication in psychiatric encounters has on treatment. Psychiatric Services, 53:1253-1265, 2002.
12. Dennis, J.L.; McBride, D.; and Peterson, P.D. "Clozapine Treatment Trials at Western State Hospital: 1990-1993." Paper presented at the 4th annual National Conference on State Mental Health Agency Services Research and Program Evaluation, Annapolis, MD, October 1993.
13. Dickey, B.; Binner, P.R.; Leff, S.; Uyeda, M.K.; Schlesinger, M.J.; and Gudeman, J.E. Containing mental health treatment costs through program design: A Massachusetts study. American Journal of Public Health, 79:863-867, 1989.
14. Drake, R.E.; Essock, S.M.; Shaner, A.; Carey, K.B.; Minkoff, K.; Kola, L.; Lynde, D.; Osher, F.C.; Clark, R.E.; and Richards, L. Implementing dual diagnosis services for clients with severe mental illness. Psychiatric Services, 52:469-476, 2001.
15. Drake, R.E.; McHugo, G.J.; Clark, R.E.; Teague, G.B.; Xie, H.; Miles, K.; and Ackerson, T.H. Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: A clinical trial. American Journal of Orthopsychiatry, 68:201-215, 1998.
16. Drake, R.E.; Yovetich, N.A.; Bebout, R.R.; Harris, M.; and McHugo, G.J. Integrated treatment for dually diagnosed homeless adults. Journal of Nervous and Mental Disease, 185:298-305, 1997.
17. Ebrahim, G.M.; Gibler, B.; Gacono, C.B.; and Hayes, G. Patient response to clozapine in a forensic psychiatric hospital. Hospital and Community Psychiatry, 45:271-273, 1994.
18. Essock, S.M.; Hargreaves, W.A.; Covell, N.H.; and Goethe, J. Clozapine's effectiveness for patients in state hospitals: Results from a randomized clinical trial. Psychopharmacology Bulletin, 32:683-697, 1996a.
19. Essock, S.M.; Hargreaves, W.A.; Dohm, F.A.; Goethe, J.W.; Carver, L.; and Hipshman, L. Clozapine eligibility among state hospital patients. Schizophrenia Bulletin, 22(1):15-25, 1996b.
20. First, M.B.; Spitzer, R.B.; Gibbon, M.; Williams, J.B.W. Structured clinical interview for DSM-IV Axis 1 Disorders. New York, NY: Biometrics Research Department, New York Psychiatric Institute, 1995.
21. Godley, S.H.; Hoewing-Roberson, R.; and Godley, M.D. Final MISA Report. Bloomington, IL: Lighthouse Institute, 1994.
22. Guyatt, G., and Rennie, D., eds. Users' Guides to the Medical Literature. Chicago, IL: American Medical Association, 2002.
23. Hellerstein, D.J.; Rosenthal, R.N.; and Miner, C.R. A prospective study of integrated outpatient treatment for substance-abusing schizophrenic patients. American Journal on Addictions, 42:33-42, 1995.
24. Ho, A.P.; Tsuang, J.W.; Liberman, R.P.; Wang, R.; Wilkins, J.N.; Eckman, T.A.; and Shaner, A.L. Achieving effective treatment of patients with chronic psychotic illness and comorbid substance dependence. American Journal of Psychiatry, 156:1765-1770, 1999.
25. Hogan, M.F. Spending too much on mental illness in all the wrong places. Psychiatric Services, 53:1251-1252, 2002.
26. Horvitz-Lennon, M.; Normand, S.L.; Gaccioni, P.; and Frank, R.G. Partial versus full hospitalization for adults in psychiatric distress: A systematic review of the published literature (1957-1997). American Journal of Psychiatry, 158:676-685, 2001.
27. Jerrell, J., and Ridgely, M. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment. Psychiatric Services, 46:233-238, 1995.
28. Jerrell, J.M., and Ridgely, M.S. Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs. Psychiatric Services, 50:109-112, 1999.
29. Kasprow, W.J.; Rosenheck, R.; Frisman, L.; and DiLella, D. Residential treatment for dually diagnosed homeless veterans: A comparison of program types. American Journal on Addictions, 8:34-43, 1999.
30. Lehman, A.; Herron, J.; Schwartz, R.; and Myers, C. Rehabilitation for young adults with severe mental illness and substance use disorders: A clinical trial. Journal of Nervous and Mental Disease, 181:86-90, 1993.
31. Mallya, A.R.; Roos, P.D.; and Roebuck-Colgan, K. Restraint, seclusion, and clozapine. Journal of Clinical Psychiatry, 53:395-397, 1992.
32. McHugo, G.J.; Drake, R.E.; Teague, G.B.; and Xie, H. Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services, 50:818-824, 1999.
33. Morrison, C.J.; Janssen, T.J.; and Motter, J.L. Medicare Mental Health Demonstration: Final Report. Contract # HHS-100-80-0148. Washington, DC: Office of the Assistant Secretary for Planning and Evaluation, DHHS, June 30, 1985.
34. Mueser, K.T.; Drake, R.E.; and Noordsy, D.L. Integrated mental health and substance abuse treatment for severe psychiatric disorders. Journal of Practical Psychiatry and Behavioral Health, 4:129-139, 1998.
35. National Advisory Mental Health Council. Bridging Science and Service. NIH Publication No. 99-4353. Bethesda, MD: National Institute of Mental Health, 1999.
36. Office of the Inspector General. Review of Partial Hospitalization Services Provided Through Community Mental Health Centers. Publication No. A-04-98-02146. Washington, DC: Department of Health and Human Services, October 5, 1998.
37. Reid, W.H.; Mason, M.; and Toprac, M. Savings in hospital bed-days related to treatment with clozapine. Hospital and Community Psychiatry, 45:261-264, 1994.
38. Rosenheck, R.; Cramer, J.; Weichun, X; Thomas, J.; Henderson, W.; Frisman, L.; Fye, C.; and Charney, D. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. New England Journal of Medicine, 337:809-815, 1997.
39. Unützer, J.; Patrick, D.L.; Simon, G.; Grembowski, D.; Walker, E.; Rutter, C.; and Katon, W. Depressive symptoms and the cost of health services in older adults: A 4-year prospective study. JAMA, 277:1618-1623, 1997.
40. Wells, K.B., and Sherbourne, C.D. Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices. Archives of General Psychiatry, 56:897-904, 1999.
41. Wilson, W.H. Clinical review of clozapine treatment in a state hospital. Hospital and Community Psychiatry, 43:700-703, 1992.
42. Wilson, W.H., and Claussen, A.M. "Clozapine in the State Hospital: Outcome at 18 Months." Paper presented at the 34th annual meeting of the NIMH New Clinical Drug Evaluation Unit, Marco Island, FL, May-June 1994.
43. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA, 288:321-333, 2002.